BREAKTHROUGH T1D
Supportive Technologies for the Scaling of Manufactured Islet Replacement Therapies RFA Grant
Supportive Technologies for the Scaling of Manufactured Islet Replacement Therapies RFA Grant is a funding opportunity from BREAKTHROUGH T1D, up to $600.0K. Its application deadline is not stated in the source record.
We could not verify this deadline.
This listing carries no application deadline we can confirm, so it may no longer be open. Check the official solicitation before investing time, and create a free account to see opportunities we can verify are live.
Overview
Breakthrough T1D Request for Applications: Supportive Technologies for the Scaling of Manufactured Islet Replacement Therapies Summary The goal of this funding opportunity is to improve the efficiency of scaling protocols for manufactured islet cell therapies for type 1 diabetes (T1D) via development of supportive…